Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

PURPOSE: Adoptive immunotherapy using tumor-infiltrating lymphocytes represents an effective cancer treatment for patients with metastatic melanoma. The NY-ESO-1 cancer/testis antigen, which is expressed in 80% of patients with synovial cell sarcoma and approximately 25% of patients with melanoma an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Robbins, Paul F., Morgan, Richard A., Feldman, Steven A., Yang, James C., Sherry, Richard M., Dudley, Mark E., Wunderlich, John R., Nahvi, Azam V., Helman, Lee J., Mackall, Crystal L., Kammula, Udai S., Hughes, Marybeth S., Restifo, Nicholas P., Raffeld, Mark, Lee, Chyi-Chia Richard, Levy, Catherine L., Li, Yong F., El-Gamil, Mona, Schwarz, Susan L., Laurencot, Carolyn, Rosenberg, Steven A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2011
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3068063/
https://ncbi.nlm.nih.gov/pubmed/21282551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.32.2537
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados